Results 191 to 200 of about 92,349 (287)

Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs

, 2001
Laura W. Tseng, Dez Hughes, Urs Giger
openalex   +1 more source

Evaluating the prevalence and severity of metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care

Journal of Internal Medicine, EarlyView.
Abstract Background and aims The prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) has increased during the epidemic of obesity. Type 2 diabetes mellitus (T2DM) is associated with progressive MASLD. Therefore, many guidelines recommend screening for MASLD in patients with T2DM.
Wile Balkhed, Martin Bergram, Fredrik Iredahl, Markus Holmberg, Carl Edin, Carl‐Johan Carlhäll, Tino Ebbers, Pontus Henriksson, Christian Simonsson, Karin Rådholm, Gunnar Cedersund, Mikael Forsgren, Olof Dahlqvist Leinhard, Cecilia Jönsson, Peter Lundberg, Stergios Kechagias, Nils Dahlström, Patrik Nasr, Mattias Ekstedt   +18 more
wiley   +1 more source

Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Predictor for Sepsis Mortality in Children Admitted to Pediatric Intensive Care Unit (PICU): A Comparison With Prothrombin Time/International Normalized Ratio (PT/INR) and Urea/Creatinine Ratio. [PDF]

Cureus
Abdelrazic MI, Abdel Hakeem GL, Hanna MS, Mohamed OM, Ismail DE, Abuelela IS.   +5 more
europepmc   +1 more source

Evaluation of a Best Practice Advisory on Ordering Prothrombin Time, International Normalized Ratio, and Partial Thromboplastin Time Tests.

JAMA Intern Med, 2022
Breeden M, Bernstein SJ, Hayward RA, Fendrick AM.   +3 more
europepmc   +1 more source

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time. [PDF]

Sci Rep, 2021
Kim SM, Kim SI, Yu G, Kim JS, Hong SI, Chae B, Shin YS, Kim YJ, Jang S, Kim WY.   +9 more
europepmc   +1 more source

Gaucher disease, state of the art and perspectives

Journal of Internal Medicine, EarlyView.
Abstract Knowledge about Gaucher disease (GD), considered a model for rare diseases, has considerably increased since its discovery. The pathophysiology of this lysosomal disorder is better known, and specific therapies that can control many aspects of the disease have been developed, particularly for the most common form, Type 1 GD.
Fabrice Camou, Marc G. Berger
wiley   +1 more source

Zinc supplementation with polaprezinc was associated with improvements in albumin, prothrombin time activity, and hemoglobin in chronic liver disease. [PDF]

J Clin Biochem Nutr
Abiru S, Kugiyama Y, Suehiro T, Motoyoshi Y, Saeki A, Nagaoka S, Yamasaki K, Komori A, Yatsuhashi H.   +8 more
europepmc   +1 more source

The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma. [PDF]

Biomed Res Int, 2021
Geng C, Yang G, Wang H, Zhang Z, Zhou H, Chen W.   +5 more
europepmc   +1 more source

Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease [PDF]

, 2010
Armando Tripodi, Trevor Baglin, Annie Robert, Steve Kitchen, Ton Lisman, J.F. Trotter   +5 more
openalex   +1 more source

The long‐term outcome and changes in tricuspid regurgitation pressure gradient in dogs diagnosed with pulmonary hypertension and Angiostrongylus vasorum infestation

Journal of Small Animal Practice, EarlyView.
Objectives Angiostrongylus vasorum (AV) is a metastrongylid parasite that has been associated with pulmonary hypertension (PH) in dogs. The objectives of the study were to describe the clinical presentation of dogs with AV and PH, document changes in tricuspid regurgitation maximum pressure gradient (TR Max PG) in subsequent months and years, record ...
R. Turner, D. Connolly, D. Brodbelt, S. Cortellini   +3 more
wiley   +1 more source